Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin intermediate-resistant Staphylococcus aureus

T F Turco1, G P Melko, J R Williams

  • 1Pharmacy Department, Our Lady of Lourdes Medical Center, Camden, NJ 08103, USA.

The Annals of Pharmacotherapy
|July 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inefficient transfer of diatoms through the subpolar Southern Ocean twilight zone.

Nature geoscience·2025
Same author

In Situ Particle Measurements Deemphasize the Role of Size in Governing the Sinking Velocity of Marine Particles.

Geophysical research letters·2022
Same author

Patellofemoral contact forces and knee gait mechanics 3 months after ACL reconstruction are associated with cartilage degradation 24 months after surgery.

Osteoarthritis and cartilage·2022
Same author

Observation of ultracold atomic bubbles in orbital microgravity.

Nature·2022
Same author

Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules.

European journal of neurology·2020
Same author

Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder.

Drug and alcohol dependence·2019
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
Same journal

Modified vs Full Lead-in Dose Apixaban and Rivaroxaban for Treatment of Acute Venous Thromboembolism.

The Annals of pharmacotherapy·2026
Same journal

A Comparison of Phenobarbital Dosing Strategies for the Treatment of Alcohol Withdrawal Syndrome.

The Annals of pharmacotherapy·2026
See all related articles

Prolonged vancomycin use for recurrent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia led to vancomycin intermediate-resistant Staphylococcus aureus (VISA). Strict infection control prevented further spread of this resistant organism.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Recurrent bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA) poses a significant treatment challenge.
  • Vancomycin is a critical antibiotic for treating MRSA infections, but resistance is a growing concern.

Observation:

  • A patient with a history of recurrent MRSA bacteremia received vancomycin intermittently for 18 of 23 weeks.
  • After prolonged treatment, an MRSA isolate exhibited intermediate resistance to vancomycin (minimum inhibitory concentration of 8 µg/mL).
  • This represented the third reported case of vancomycin intermediate-resistant Staphylococcus aureus (VISA).

Findings:

  • Prolonged, intermittent vancomycin administration is strongly associated with the development of VISA.

Related Experiment Videos

  • Effective infection control measures were crucial in preventing the transmission of VISA within the healthcare setting.

    • Implications:

    • The case highlights the critical need for judicious antimicrobial prescribing and robust infection control protocols.
    • Enhanced surveillance and stewardship programs are essential to combat the emergence and spread of antibiotic-resistant bacteria like VISA.